Opzelura Ruxolitinib Cream

Opzelura Ruxolitinib Cream

Opzelura Ruxolitinib 1.5% Cream is an advanced topical medication containing Ruxolitinib, a Janus Kinase (JAK) inhibitor It is prescribed for eligible patients with nonsegmental vitiligo and mild to moderate atopic dermatitis. It works by targeting specific pathways involved in immune system activity and skin inflammation.

This treatment should be used under the supervision of a qualified dermatologist.

Benefits

1. Helps treat nonsegmental vitiligo.
2. Supports repigmentation of affected skin in vitiligo.
3. Helps manage mild to moderate atopic dermatitis.
4. Helps reduce eczema-related itching and redness.
5. Targets specific immune pathways involved in skin conditions.
6. Provides targeted topical treatment.

How To Use

1. Use only as prescribed by a qualified dermatologist.
2. Apply a thin layer to the affected skin areas as directed.
3. Follow the prescribed application frequency.
4. Wash your hands after application unless treating your hands.
5. Avoid contact with eyes, mouth and mucous membranes.
6. Do not cover treated areas with airtight dressings unless directed by your doctor.